• Explore /
  • Poster
  • / Prognostic value of free testosterone (FT) levels during salvage chemotherapy with carboplatin plus weekly docetaxel in metastatic castration- and docetaxel-resistant prostate cancer (mDRPC).

Prognostic value of free testosterone (FT) levels during salvage chemotherapy with carboplatin plus weekly docetaxel in metastatic castration- and docetaxel-resistant prostate cancer (mDRPC).

Abstract Poster

Authors

null

Christoph W. Reuter

Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

Christoph W. Reuter , Michael A. Morgan , Christoph von Klot , Axel S. Merseburger , Martin H Fenner , Philipp Ivanyi , Viktor Gruenwald , Arnold Ganser

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Prostate) Cancer

Track

Genitourinary Cancer

Sub Track

Prostate Cancer

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 5084)

DOI

10.1200/jco.2014.32.15_suppl.5084

Abstract #

5084

Poster Bd #

213

Abstract Disclosures

Similar Posters

First Author: Christoph W. Reuter

First Author: Christoph Reuter

First Author: Christoph W. Reuter

First Author: Christoph W. Reuter